Arca
Skip to content
Tools
Tools

CALCR, RAMP1: Amylin receptor AMY1, CALCR/RAMP1

Complex in Homo sapiens that 2 drugs act on.

  • Drugs that act on it: 2
  • Approved: 1
  • In phases 1 to 3: 1
  • Sponsors: 1

Who is on it, and how far along

Every drug ChEMBL records acting on CALCR, by the furthest stage it has reached for any use, coloured by modality.

How to read this

Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.

  • Protein or peptide 2

Approved1

  • Pramlintide

Phase 30

    Phase 21

    • Davalintide

    Phase 10

      The landscape

      Every drug acting on it, furthest along first. The sponsor is the US application holder where there is one, else the industry lead sponsor of most of its registered trials.
      PramlintideBoxed warningApprovedAstraZeneca PharmaceuticalsProtein or peptideAgonistAmylin receptor AMY1, CALCR/RAMP1 agonist6
      DavalintidePhase 2AstraZeneca PharmaceuticalsProtein or peptideAgonistAmylin receptor AMY1, CALCR/RAMP1 agonist0

      Open trials

      The most recently posted recruiting or ongoing trials naming each drug (up to 8 a drug), 6 in all, from ClinicalTrials.gov.
      Outpatient Pramlintide StudyPramlintideNot applicableNot yet recruitingOregon Health and Science UniversityNov 3, 2026
      Postprandial Regulation of Bone Perfusion in Healthy IndividualsPramlintideNot applicableNot yet recruitingUniversity of CopenhagenJul 1, 2026
      Pancreatic Polypeptide as a Modulator of Amylin- Induced Satiety in Healthy HumansPramlintideNot applicableRecruitingUniversity Hospital, Gentofte, CopenhagenApr 1, 2026
      Hypersensitivity to Amylin in Post-Traumatic HeadachePramlintideNot applicableRecruitingDanish Headache CenterJan 14, 2026
      Amylin-Induced Migraine Attacks Without AuraPramlintideNot applicableNot yet recruitingDanish Headache CenterJan 14, 2026
      Multi-Center Development of a Novel Diagnostic Test for Alzheimer's DiseasePramlintideEarly phase 1Active, not recruitingBoston UniversityJun 19, 2018

      Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2111189, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-21. ChEMBL and Open Targets

      Esc

      Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

      Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.